Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Ozone Treatment on Coronary Flow Reserve in Patients With Heart Failure Having Reduced Ejection Fraction

NCT07134972 is registered in ClinicalTrials.gov with Ekrem Bilal Karaayvaz as lead sponsor.

NCT NCT07134972
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07134972 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Ozone Treatment on Coronary Flow Reserve in Patients With Heart Failure Having Reduced Ejection Fraction
Lead sponsor
Ekrem Bilal Karaayvaz
Phase
Not applicable
Overall status
Completed
Start date
January 14, 2024
Completion date
December 21, 2024
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure and reduced ejection fraction